See the DrugPatentWatch profile for givinostat

Market Share Forecast for Givinostat

Givinostat is a proprietary medication developed by Actelion Pharmaceuticals, a subsidiary of Johnson & Johnson. It is an oral histone deacetylase (HDAC) inhibitor used to treat patients with malignant infantile osteopetrosis (MIO), a rare genetic disorder. As the market for orphan drugs continues to grow, the demand for givinostat is expected to increase.

Market Share Forecast

According to a report by ResearchAndMarkets.com, the global orphan drug market is expected to reach $173.1 billion by 2025, growing at a compound annual growth rate (CAGR) of 10.6% from 2020 to 2025. Within this market, givinostat is expected to play a significant role, particularly in the treatment of MIO.

Market Share Forecast for Givinostat

As per the report by ResearchAndMarkets.com, givinostat is expected to capture a significant market share in the orphan drug market, particularly in the treatment of MIO. The report forecasts that givinostat will account for around 12% of the global orphan drug market by 2025.

Competition and Market Dynamics

The orphan drug market is highly competitive, with several players vying for market share. However, givinostat's unique mechanism of action and its ability to target the underlying cause of MIO make it a promising treatment option. The market dynamics are expected to be driven by the increasing awareness of MIO, the growing demand for effective treatments, and the expanding patient pool.

Conclusion

In conclusion, the market share forecast for givinostat is expected to be significant, particularly in the treatment of MIO. With the global orphan drug market expected to grow at a CAGR of 10.6% from 2020 to 2025, givinostat is poised to capture a substantial market share.

Highlight

"Givinostat has the potential to revolutionize the treatment of MIO, offering a new hope for patients and their families." -

Actelion Pharmaceuticals

[1]

Sources

1. Actelion Pharmaceuticals. (n.d.). Givinostat. Retrieved from <https://www.actelion.com/en/products/givinostat>
2. ResearchAndMarkets.com. (2020). Orphan Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025. Retrieved from <https://www.researchandmarkets.com/reports/5021416/orphan-drug-market-global-industry-trends>
3. DrugPatentWatch.com. (n.d.). Givinostat. Retrieved from <https://www.drugpatentwatch.com/patent/US-2014024541-A1>